FY 2025
Loading financial data...
|
Chart |
FY21
Dec 31, 2021
|
FY22
Dec 31, 2022
|
FY23
Dec 31, 2023
|
FY24
Dec 31, 2024
|
FY25
Dec 31, 2025
|
TTM
Trailing 12M
|
|---|---|---|---|---|---|---|---|
|
Revenue
Total sales generated. |
|
$292.11 B | $322.47 B | $357.78 B | $372.81 B | $402.07 B | $407.91 B |
|
Cost of Revenue Direct cost of goods/services. |
|
$239.99 B | $267.97 B | $303.35 B | $321.41 B | $346.71 B | $351.32 B |
Gross Profit Revenue minus cost of revenue. |
|
$52.12 B | $54.50 B | $54.43 B | $51.40 B | $55.36 B | $56.59 B |
|
Operating Expense
Costs to run business. 
|
|
$38.81 B | $46.55 B | $40.69 B | $42.89 B | $44.98 B | $50.62 B |
Operating Income Profit from operations. |
|
$13.31 B | $7.95 B | $13.74 B | $8.52 B | $10.39 B | $5.97 B |
|
Net Interest Income
Interest income minus expense.
|
|
-$2.50 B | -$2.29 B | -$2.66 B | -$2.96 B | -$3.12 B | -$3.11 B |
Non-Operating Income (ex-Int) Income outside core operations. |
|
$270.00 M | -$169.00 M | -$88.00 M | -$590.00 M | $5.13 B | -$599.00 M |
Total Other Income (Net) Net non-operating items. |
|
-$2.77 B | -$2.12 B | -$2.57 B | -$2.37 B | -$8.25 B | -$2.51 B |
Income Before Tax Profit before taxes. |
|
$10.54 B | $5.84 B | $11.17 B | $6.15 B | $2.14 B | $3.46 B |
Income Tax Expense Taxes on income. |
|
$2.55 B | $1.51 B | $2.81 B | $1.56 B | $408.00 M | $568.00 M |
|
Net Income
Final profit.
|
|
$8.00 B | $4.31 B | $8.34 B | $4.61 B | $1.77 B | $2.93 B |
|
Earnings Per Share
Company profit allocated to each outstanding share. |
|||||||
EPS Earnings per share. Formula: Net Income ÷ Shares |
|
$6.00 | $3.29 | $6.49 | $3.66 | $1.40 | $2.31 |
Diluted EPS EPS including dilution. Formula: Net Income ÷ Diluted Shares |
|
$5.95 | $3.26 | $6.47 | $3.66 | $1.39 | $2.27 |
|
Shares for EPS
Number of shares used to calculate EPS. |
|||||||
Weighted Average Shares Outst. Avg shares used for EPS. |
|
1.32 B | 1.31 B | 1.29 B | 1.26 B | 1.27 B | 1.27 B |
Diluted Average Shares Outst. Shares including dilution. |
|
1.33 B | 1.32 B | 1.29 B | 1.26 B | 1.27 B | 1.28 B |
| Supplemental Items | |||||||
EBIT Earnings before interest and tax. |
|
$13.04 B | $8.12 B | $13.83 B | $9.11 B | $5.26 B | $6.57 B |
EBITDA Earnings before interest, tax, D&A. |
|
$17.53 B | $12.35 B | $18.20 B | $13.68 B | $9.86 B | $11.13 B |
Depreciation and Amortization Non-cash expense for assets. |
|
$4.49 B | $4.22 B | $4.37 B | $4.60 B | $4.61 B | $4.57 B |
| Company Report |
FY 2025
CVS Health Corporation's Balance Sheet
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading balance sheet when needed... |
CVS Health Corporation's Cash flow
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading cash flow statement when needed... |
CVS Health Corporation's Profitability
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading profitability metrics when needed... |
CVS Health Corporation's Ratios
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
